News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
532,889 Results
Type
Article (30339)
Company Profile (93)
Press Release (502450)
Multimedia
Podcasts (110)
Webinars (15)
Section
Business (172826)
Career Advice (1643)
Deals (28411)
Drug Delivery (121)
Drug Development (66494)
Employer Resources (126)
FDA (12262)
Job Trends (11446)
News (262265)
Policy (25453)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (1957)
Academic (1)
Accelerated approval (47)
ADA (32)
Adcomms (25)
Allergies (164)
Alliances (38760)
ALS (196)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (466)
Approvals (12812)
Artificial intelligence (577)
ASCO (274)
Autoimmune disease (312)
Automation (46)
Bankruptcy (262)
Best Places to Work (8828)
BIO (51)
BIOSECURE Act (22)
Biosimilars (206)
Biotechnology (49)
Bladder cancer (177)
Brain cancer (70)
Breast cancer (632)
Cancer (5225)
Cardiovascular disease (436)
Career advice (1383)
Career pathing (40)
CAR-T (309)
CDC (43)
Celiac Disease (3)
Cell therapy (797)
Cervical cancer (50)
Clinical research (59585)
Collaboration (1827)
Commercialization (1)
Company closure (2)
Compensation (673)
Complete response letters (76)
COVID-19 (2162)
CRISPR (95)
C-suite (1036)
Cystic fibrosis (118)
Data (7482)
Decentralized trials (1)
Denatured (32)
Depression (157)
Dermatology (77)
Diabetes (514)
Diagnostics (4829)
Digital health (41)
Diversity (9)
Diversity, equity & inclusion (33)
Drug discovery (301)
Drug pricing (172)
Drug shortages (35)
Duchenne muscular dystrophy (256)
Earnings (63043)
Editorial (54)
Employer branding (11)
Employer resources (114)
Events (77760)
Executive appointments (950)
FDA (15767)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (16)
Frontotemporal dementia (29)
Funding (1474)
Gene editing (201)
Generative AI (54)
Gene therapy (606)
GLP-1 (927)
Government (3705)
Grass and pollen (7)
Guidances (391)
Healthcare (13197)
Hematology (159)
HIV (79)
Huntington's disease (44)
IgA nephropathy (116)
Immunology and inflammation (239)
Immuno-oncology (89)
Indications (196)
Infectious disease (2447)
Inflammatory bowel disease (193)
Inflation Reduction Act (10)
Influenza (104)
Intellectual property (281)
Interviews (254)
IPO (12697)
IRA (47)
Job creations (2905)
Job search strategy (1188)
JPM (50)
Kidney cancer (19)
Labor market (77)
Layoffs (446)
Leadership (37)
Legal (5550)
Liver cancer (84)
Longevity (23)
Lung cancer (700)
Lymphoma (426)
Machine learning (48)
Management (49)
Manufacturing (981)
Marketing (6)
MASH (184)
Medical affairs (1)
Medical device (8480)
Medtech (8609)
Mergers & acquisitions (16888)
Metabolic disorders (1328)
mRNA (167)
Multiple sclerosis (172)
NASH (21)
Neurodegenerative disease (338)
Neuropsychiatric disorders (91)
Neuroscience (2774)
Neurotech (1)
NextGen: Class of 2026 (4527)
Non-profit (3392)
Now hiring (43)
Obesity (610)
Opinion (276)
Ovarian cancer (218)
Pain (232)
Pancreatic cancer (290)
Parkinson's disease (314)
Partnered (30)
Patents (555)
Patient recruitment (670)
Peanut (47)
People (46694)
Pharmaceutical (37)
Pharmacy benefit managers (30)
Phase 1 (17743)
Phase 2 (26171)
Phase 3 (20585)
Pipeline (8899)
Policy (290)
Postmarket research (1981)
Preclinical (7089)
Press Release (67)
Prostate cancer (281)
Psychedelics (48)
Radiopharmaceuticals (286)
Rare diseases (1013)
Real estate (4462)
Recruiting (52)
Regulatory (21166)
Reports (35)
Research institute (1790)
Resumes & cover letters (273)
Rett syndrome (41)
RNA editing (19)
RSV (69)
Schizophrenia (159)
Series A (265)
Series B (179)
Service/supplier (2)
Sickle cell disease (112)
Special edition (16)
Spinal muscular atrophy (137)
Sponsored (40)
Startups (2778)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (84)
The Weekly (76)
Vaccines (845)
Venture capital (97)
Weight loss (379)
Women's health (90)
Worklife (16)
Date
Today (24)
Last 7 days (380)
Last 30 days (1472)
Last 365 days (24048)
2026 (13610)
2025 (23671)
2024 (27294)
2023 (30936)
2022 (40190)
2021 (42684)
2020 (41622)
2019 (34142)
2018 (25954)
2017 (25171)
2016 (23788)
2015 (28203)
2014 (21236)
2013 (17422)
2012 (18638)
2011 (19506)
2010 (17447)
Location
Africa (629)
Alabama (62)
Alaska (6)
Arizona (207)
Arkansas (10)
Asia (39848)
Australia (6754)
California (10547)
Canada (3295)
China (1633)
Colorado (458)
Connecticut (474)
Delaware (330)
Europe (75342)
Florida (1683)
Georgia (306)
Hawaii (2)
Idaho (34)
Illinois (891)
India (100)
Indiana (496)
Iowa (6)
Japan (556)
Kansas (106)
Kentucky (40)
Louisiana (37)
Maine (60)
Maryland (1344)
Massachusetts (7605)
Michigan (232)
Minnesota (539)
Mississippi (1)
Missouri (121)
Montana (18)
Nebraska (23)
Nevada (123)
New Hampshire (65)
New Jersey (3240)
New Mexico (19)
New York (2955)
North Carolina (1361)
North Dakota (3)
Northern California (5312)
Ohio (296)
Oklahoma (13)
Oregon (28)
Pennsylvania (2100)
Puerto Rico (29)
Rhode Island (30)
South America (905)
South Carolina (79)
Southern California (4298)
Tennessee (174)
Texas (1635)
United States (37936)
Utah (259)
Vermont (1)
Virginia (306)
Washington D.C. (63)
Washington State (877)
West Virginia (4)
Wisconsin (99)
Wyoming (2)
532,889 Results for "china resources pharmaceutical group limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall
June 22, 2026
·
6 min read
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
AstraZeneca and CSPC Pharmaceutical Group have already inked two other agreements this year, including an obesity-focused deal in January and one focused on chronic diseases in June.
July 2, 2026
·
2 min read
·
Tristan Manalac
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
Speaking to media on Tuesday, BIO CEO John Crowley complimented China’s rise as a biotech powerhouse but said U.S. policy needs to protect and maintain America’s lead.
June 24, 2026
·
2 min read
·
Annalee Armstrong
China
Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact
Eli Lilly and the Haisco Pharmaceutical Group have yet to disclose what specific indications they plan to prioritize.
June 2, 2026
·
1 min read
·
Tristan Manalac
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
July 10, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
GNI Group Completes Acquisition of AYUMI Pharmaceutical
July 1, 2026
·
5 min read
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
Pfizer continues its dealmaking spree by striking a back-heavy partnership with China’s Innovent Biologics to assemble a pipeline of antibody-based therapies for cancer.
May 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
June 22, 2026
·
14 min read
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
Lilly has already spent more than $25 billion in potential business development commitments this year, including the $6.3 billion buyout of Centessa Pharmaceuticals that closed today.
June 24, 2026
·
2 min read
·
Tristan Manalac
1 of 53,289
Next
